Yatharth Hospital
Stock Snapshot
Price Performance
Vista Outlook
View Technicals Analysis →Basis of our Recommendation
Yatharth Hospital's management has articulated a clear growth strategy focused on expanding its operational bed capacity to 5,000 by FY29, leveraging a cluster-based approach in high-potential regions. This strategy is expected to enhance revenue through increased average revenue per occupied bed (ARPOB) as new facilities mature and integrate high-end tertiary care services. Despite facing execution risks associated with rapid expansion, management's confidence in operational efficiency and strong internal accruals supports Vista's forecast of moderated revenue growth and stable margins. The healthcare sector's current dynamics, characterized by stable pricing power but emerging margin pressures, align with Vista's outlook of a fair valuation and a cautious investment recommendation. Over the next 12-24 months, key opportunities include the successful integration of new assets and the potential for ARPOB growth, while watchpoints include execution risks and competitive pressures that could impact margins. Overall, Yatharth Hospital is positioned to capitalize on the growing demand for organized healthcare, although vigilance is required regarding operational execution and market dynamics
Why We Like This Stock
- Management's aggressive expansion strategy aims to increase operational bed capacity to 5,000, enhancing revenue potential
- Focus on high-end tertiary care services is expected to drive ARPOB growth, supporting revenue stability
- Strong internal accruals and operational efficiency provide a buffer against execution risks
Things To Watch Out For
- Execution risks related to rapid capacity expansion could impact operational performance
- Emerging margin pressures in the healthcare sector may challenge profitability
- Competitive dynamics in the fragmented healthcare market could affect market share and pricing power
Key Parameters
Financial Snapshot
| Actuals | Forecast | ||||
|---|---|---|---|---|---|
| FY24 | FY25 | FY26 | FY27 | FY28 | |
| Revenue (Cr.) | 635 | 860 | 1,207 | 1,376 | 1,735 |
| Profit Before Tax (Cr.) | 157 | 170 | 224 | 210 | 283 |
| PBT Margin | 24.7% | 19.8% | 1855.8% | 15.2% | 16.3% |
| Net Profit (Cr.) | 116 | 122 | 170 | 159 | 208 |
| Earnings Per Share | 12.0 | 12.7 | 18.2 | 16.0 | 21.6 |
Analyst Recommendations
| Broker | Recommendation | Target Price | Date |
|---|---|---|---|
| Choice Equity | ▲ Buy | 1,100 | 12-Aug-2026 |
| Nuvama | ▲ Buy | 950 | 27-May-2026 |
Company Overview
Show Company Profile
Yatharth Hospital & Trauma Care Services Limited, together with its subsidiaries, owns and operates super-specialty hospitals in India. The company offers services in the areas of medicine, cardiology, neurosciences, general surgery, nephrology and urology, pediatrics, gastroenterology, pulmonology, gynecology, orthopedics, spine and rheumatology, plastic and cosmetic surgery, ear, nose, throat, endocrinology, critical care, dermatology, nuclear medicine, and cancer and bone marrow transplant. It also provides services in the areas of GI surgery and liver transplant, robotic surgery, kidney transplant, IVF and fertility, emergency medicine, ophthalmology, dentistry, psychology and psychiatry, physiotherapy and rehabilitation, anesthesiology, radiology, pathology and laboratory medicine, nutrition and health, interventional spine and pain medicine, neurology, neurosurgery, and cardiovascular and thoracic surgery. In addition, the company sells medicines and canteen food. The company was incorporated in 2008 and is based in Noida, India.